Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 36.4% in March

Nyxoah S.A. (NASDAQ:NYXH) saw a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 63,700 shares, a decline of 36.4% from the February 28th total of 100,200 shares. Approximately 0.4% of the shares of the stock are short sold. Based on an average trading volume of 47,400 shares, the short-interest ratio is presently 1.3 days.

Nyxoah Trading Down 8.8 %

Shares of NYXH stock traded down $0.67 on Monday, hitting $6.98. 92,005 shares of the company’s stock traded hands, compared to its average volume of 46,856. The stock has a market capitalization of $237.74 million, a price-to-earnings ratio of -3.73 and a beta of 1.42. The company’s fifty day simple moving average is $10.35 and its 200 day simple moving average is $9.36. Nyxoah has a one year low of $6.76 and a one year high of $13.50. The company has a debt-to-equity ratio of 0.21, a quick ratio of 4.95 and a current ratio of 5.28.

Nyxoah (NASDAQ:NYXH) last announced its quarterly earnings data on Thursday, March 13th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%. The company had revenue of $1.35 million for the quarter, compared to the consensus estimate of $2.02 million. Equities analysts forecast that Nyxoah will post -1.91 EPS for the current year.

Hedge Funds Weigh In On Nyxoah

Large investors have recently bought and sold shares of the stock. Kovack Advisors Inc. grew its holdings in shares of Nyxoah by 100.0% in the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock worth $160,000 after purchasing an additional 10,000 shares during the last quarter. Ameriprise Financial Inc. purchased a new stake in Nyxoah during the 4th quarter valued at $135,000. Vestal Point Capital LP bought a new stake in Nyxoah in the 4th quarter worth $23,394,000. Renaissance Technologies LLC purchased a new position in shares of Nyxoah in the fourth quarter valued at about $187,000. Finally, Geode Capital Management LLC raised its stake in shares of Nyxoah by 19.4% during the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock valued at $137,000 after acquiring an additional 2,774 shares during the last quarter.

Analyst Ratings Changes

A number of equities research analysts have weighed in on NYXH shares. HC Wainwright lowered their price target on Nyxoah from $17.00 to $15.00 and set a “buy” rating on the stock in a research report on Wednesday, March 26th. Stifel Nicolaus decreased their price objective on Nyxoah from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, March 14th.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.